Selected research
Industry Research
Women’s Health Diagnostics Industry Research Report 2026
Market perspective
The global Women’s Health Diagnostics market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Women’s Health Diagnostics market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Women’s Health Diagnostics market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Women’s Health Diagnostics market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Women’s Health Diagnostics include Siemens, Roche, Philips, Quest Diagnostics Inc., Perkinelmer Inc., Hologic, Inc., GE Healthcare, Biomerieux SA and Becton, Dickinson and Company, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Women’s Health Diagnostics market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Women’s Health Diagnostics.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Women’s Health Diagnostics Market by Company
Siemens
Roche
Philips
Quest Diagnostics Inc.
Perkinelmer Inc.
Hologic, Inc.
GE Healthcare
Biomerieux SA
Becton, Dickinson and Company
Alere Inc.
Abbott Laboratories
Women’s Health Diagnostics Segment by Type
Diagnostic Devices
Diagnostic Tests
Women’s Health Diagnostics Segment by Application
Infectious Disease Testing
Osteoporosis Testing
Pregnancy and Fertility Testing
Breast Cancer
Sexually Transmitted Disease Testing
Others
Women’s Health Diagnostics Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Women’s Health Diagnostics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Women’s Health Diagnostics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Women’s Health Diagnostics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Women’s Health Diagnostics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Diagnostic Devices
- Diagnostic Tests
Applications
- Infectious Disease Testing
- Osteoporosis Testing
- Pregnancy and Fertility Testing
- Breast Cancer
- Sexually Transmitted Disease Testing
- Others
Companies covered
- Siemens
- Roche
- Philips
- Quest Diagnostics Inc.
- Perkinelmer Inc.
- Hologic, Inc.
- GE Healthcare
- Biomerieux SA
- Becton, Dickinson and Company
- Alere Inc.
- Abbott Laboratories
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Women’s Health Diagnostics by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Diagnostic Devices
- 2.2.3 Diagnostic Tests
- 2.3 Women’s Health Diagnostics by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Infectious Disease Testing
- 2.3.3 Osteoporosis Testing
- 2.3.4 Pregnancy and Fertility Testing
- 2.3.5 Breast Cancer
- 2.3.6 Sexually Transmitted Disease Testing
- 2.3.7 Others
- 2.4 Assumptions and Limitations
3 Women’s Health Diagnostics Breakdown Data by Type
- 3.1 Global Women’s Health Diagnostics Historic Market Size by Type (2021-2026)
- 3.2 Global Women’s Health Diagnostics Forecasted Market Size by Type (2027-2032)
4 Women’s Health Diagnostics Breakdown Data by Application
- 4.1 Global Women’s Health Diagnostics Historic Market Size by Application (2021-2026)
- 4.2 Global Women’s Health Diagnostics Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Women’s Health Diagnostics Market Perspective (2021-2032)
- 5.2 Global Women’s Health Diagnostics Growth Trends by Region
- 5.2.1 Global Women’s Health Diagnostics Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Women’s Health Diagnostics Historic Market Size by Region (2021-2026)
- 5.2.3 Women’s Health Diagnostics Forecasted Market Size by Region (2027-2032)
- 5.3 Women’s Health Diagnostics Market Dynamics
- 5.3.1 Women’s Health Diagnostics Industry Trends
- 5.3.2 Women’s Health Diagnostics Market Drivers
- 5.3.3 Women’s Health Diagnostics Market Challenges
- 5.3.4 Women’s Health Diagnostics Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Women’s Health Diagnostics Players by Revenue
- 6.1.1 Global Top Women’s Health Diagnostics Players by Revenue (2021-2026)
- 6.1.2 Global Women’s Health Diagnostics Revenue Market Share by Players (2021-2026)
- 6.2 Global Women’s Health Diagnostics Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Women’s Health Diagnostics Head Office and Area Served
- 6.4 Global Women’s Health Diagnostics Players, Product Type & Application
- 6.5 Global Women’s Health Diagnostics Manufacturers Established Date
- 6.6 Global Women’s Health Diagnostics Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Women’s Health Diagnostics Market Size (2021-2032)
- 7.2 North America Women’s Health Diagnostics Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Women’s Health Diagnostics Market Size by Country (2021-2026)
- 7.4 North America Women’s Health Diagnostics Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Women’s Health Diagnostics Market Size (2021-2032)
- 8.2 Europe Women’s Health Diagnostics Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Women’s Health Diagnostics Market Size by Country (2021-2026)
- 8.4 Europe Women’s Health Diagnostics Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Women’s Health Diagnostics Market Size (2021-2032)
- 9.2 Asia-Pacific Women’s Health Diagnostics Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Women’s Health Diagnostics Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Women’s Health Diagnostics Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Women’s Health Diagnostics Market Size (2021-2032)
- 10.2 South America Women’s Health Diagnostics Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Women’s Health Diagnostics Market Size by Country (2021-2026)
- 10.4 South America Women’s Health Diagnostics Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Women’s Health Diagnostics Market Size (2021-2032)
- 11.2 Middle East & Africa Women’s Health Diagnostics Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Women’s Health Diagnostics Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Women’s Health Diagnostics Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Siemens
- 12.1.1 Siemens Company Information
- 12.1.2 Siemens Business Overview
- 12.1.3 Siemens Revenue in Women’s Health Diagnostics Business (2021-2026)
- 12.1.4 Siemens Women’s Health Diagnostics Product Portfolio
- 12.1.5 Siemens Recent Developments
- 12.2 Roche
- 12.2.1 Roche Company Information
- 12.2.2 Roche Business Overview
- 12.2.3 Roche Revenue in Women’s Health Diagnostics Business (2021-2026)
- 12.2.4 Roche Women’s Health Diagnostics Product Portfolio
- 12.2.5 Roche Recent Developments
- 12.3 Philips
- 12.3.1 Philips Company Information
- 12.3.2 Philips Business Overview
- 12.3.3 Philips Revenue in Women’s Health Diagnostics Business (2021-2026)
- 12.3.4 Philips Women’s Health Diagnostics Product Portfolio
- 12.3.5 Philips Recent Developments
- 12.4 Quest Diagnostics Inc.
- 12.4.1 Quest Diagnostics Inc. Company Information
- 12.4.2 Quest Diagnostics Inc. Business Overview
- 12.4.3 Quest Diagnostics Inc. Revenue in Women’s Health Diagnostics Business (2021-2026)
- 12.4.4 Quest Diagnostics Inc. Women’s Health Diagnostics Product Portfolio
- 12.4.5 Quest Diagnostics Inc. Recent Developments
- 12.5 Perkinelmer Inc.
- 12.5.1 Perkinelmer Inc. Company Information
- 12.5.2 Perkinelmer Inc. Business Overview
- 12.5.3 Perkinelmer Inc. Revenue in Women’s Health Diagnostics Business (2021-2026)
- 12.5.4 Perkinelmer Inc. Women’s Health Diagnostics Product Portfolio
- 12.5.5 Perkinelmer Inc. Recent Developments
- 12.6 Hologic, Inc.
- 12.6.1 Hologic, Inc. Company Information
- 12.6.2 Hologic, Inc. Business Overview
- 12.6.3 Hologic, Inc. Revenue in Women’s Health Diagnostics Business (2021-2026)
- 12.6.4 Hologic, Inc. Women’s Health Diagnostics Product Portfolio
- 12.6.5 Hologic, Inc. Recent Developments
- 12.7 GE Healthcare
- 12.7.1 GE Healthcare Company Information
- 12.7.2 GE Healthcare Business Overview
- 12.7.3 GE Healthcare Revenue in Women’s Health Diagnostics Business (2021-2026)
- 12.7.4 GE Healthcare Women’s Health Diagnostics Product Portfolio
- 12.7.5 GE Healthcare Recent Developments
- 12.8 Biomerieux SA
- 12.8.1 Biomerieux SA Company Information
- 12.8.2 Biomerieux SA Business Overview
- 12.8.3 Biomerieux SA Revenue in Women’s Health Diagnostics Business (2021-2026)
- 12.8.4 Biomerieux SA Women’s Health Diagnostics Product Portfolio
- 12.8.5 Biomerieux SA Recent Developments
- 12.9 Becton, Dickinson and Company
- 12.9.1 Becton, Dickinson and Company Company Information
- 12.9.2 Becton, Dickinson and Company Business Overview
- 12.9.3 Becton, Dickinson and Company Revenue in Women’s Health Diagnostics Business (2021-2026)
- 12.9.4 Becton, Dickinson and Company Women’s Health Diagnostics Product Portfolio
- 12.9.5 Becton, Dickinson and Company Recent Developments
- 12.10 Alere Inc.
- 12.10.1 Alere Inc. Company Information
- 12.10.2 Alere Inc. Business Overview
- 12.10.3 Alere Inc. Revenue in Women’s Health Diagnostics Business (2021-2026)
- 12.10.4 Alere Inc. Women’s Health Diagnostics Product Portfolio
- 12.10.5 Alere Inc. Recent Developments
- 12.11 Abbott Laboratories
- 12.11.1 Abbott Laboratories Company Information
- 12.11.2 Abbott Laboratories Business Overview
- 12.11.3 Abbott Laboratories Revenue in Women’s Health Diagnostics Business (2021-2026)
- 12.11.4 Abbott Laboratories Women’s Health Diagnostics Product Portfolio
- 12.11.5 Abbott Laboratories Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst